FDA Inspection 1012214 — University of Pittsburgh Cancer Institute Cancer Service

University of Pittsburgh Cancer Institute Cancer Service — FEI 3000203655

The FDA completed an inspection of University of Pittsburgh Cancer Institute Cancer Service on April 17, 2017 in Erie, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 17, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Erie, PA (United States)